Expression of major histocompatibility complex class II antigens and interleukin-1 by epithelial cells of Warthin's tumor
β Scribed by Yuzo Ogawa; Sung-Soo Hong; Satoru Toyosawa; Chee-Keong Chang; Toshio Yagi
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 923 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Polarized expression of major histocompatibility complex class I molecules in human endometrial Department of Obstetrics and and endocervical epithelial cells Gynaecologyn and Laboratory of ## Utrecht, Utrecht The localization of major histocompatibility complex (MHC) class I molecules in human
Besides their "classical" antigenic peptide-presenting activity, major histocompatibility complex (MHC) class II antigens can activate different cellular functions in immune and nonimmune cells. However, this "nonclassical" role and its functional consequences are still substantially overlooked. In
## Abstract Normal thyroid epithelial cells lack major histocompatibility complex (MHC) Class II antigen. Oncogenic kinases involved in papillary thyroid carcinoma (PTC) trigger the expression of Class II transactivator and MHC Class II complex. However, the relationship between MHC Class II antige
## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDAβapproved antiβcancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumorβspecific immune response that is dependent on cytotoxic T lymphocytes